100% Quality Guarantee
PhD-Level Technical Support
Human Signal Transduction ELISA Kits Human NMDAR2A / GRIN2A ELISA Kit
Key Features

Human NMDAR2A/GRIN2A ELISA Kit (HUFI02522)

SKU HUFI02522
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 0.188 ng/mL
Range 0.313-20 ng/mL
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human NMDAR2A/GRIN2A ELISA Kit

The Human NMDAR2A (GRIN2A) ELISA Kit is specially designed for the precise measurement of NMDAR2A (GRIN2A) levels in human samples such as serum, plasma, and cell culture supernatants. With its exceptional sensitivity and specificity, this kit ensures accurate and consistent results, making it an excellent choice for a variety of research purposes. NMDAR2A (GRIN2A) is a critical subunit of the N-methyl-D-aspartate (NMDA) receptor, which is essential for various neurological functions including learning and memory.

Dysregulation of this receptor has been linked to conditions such as schizophrenia, epilepsy, and Alzheimer's disease, highlighting the importance of studying NMDAR2A (GRIN2A) levels as a potential biomarker for these disorders. With the Human NMDAR2A (GRIN2A) ELISA Kit, researchers can explore the role of this protein in neurological disorders, furthering our understanding of brain function and potentially leading to the development of novel therapeutic strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose